SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-040057
Filing Date
2020-08-13
Accepted
2020-08-13 16:40:44
Documents
50
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q life-10q_20200630.htm 10-Q 2111794
2 EX-31.1 life-ex311_7.htm EX-31.1 9627
3 EX-31.2 life-ex312_8.htm EX-31.2 9123
4 EX-32.1 life-ex321_9.htm EX-32.1 5502
5 EX-32.2 life-ex322_6.htm EX-32.2 5491
  Complete submission text file 0001564590-20-040057.txt   6335080

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT life-20200630.xml EX-101.INS 1252655
7 XBRL TAXONOMY EXTENSION SCHEMA life-20200630.xsd EX-101.SCH 45975
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE life-20200630_cal.xml EX-101.CAL 43915
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE life-20200630_def.xml EX-101.DEF 170017
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE life-20200630_lab.xml EX-101.LAB 363392
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE life-20200630_pre.xml EX-101.PRE 270451
Mailing Address 3545 JOHN HOPKINS COURT, STE #250 SAN DIEGO CA 92121
Business Address 3545 JOHN HOPKINS COURT, STE #250 SAN DIEGO CA 92121 858-731-8389
aTYR PHARMA INC (Filer) CIK: 0001339970 (see all company filings)

IRS No.: 203435077 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37378 | Film No.: 201099866
SIC: 2836 Biological Products, (No Diagnostic Substances)